Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

Turkish pregnant women commonly experienced skin issues like itching and acne, and doctors mainly used topical treatments due to safety concerns during pregnancy.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Cosmetics can contain harmful chemicals that may cause health issues.

Higher cholesterol levels increase aggressive prostate cancer risk.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

Obese women with PCOS are more likely to have fatty liver disease.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Group a wide range of chemicals, not just phthalates, for assessing risks to male reproductive health.

Some African American women's central scalp hair loss is linked to genetics and past fungal scalp infections, with more research needed on other causes.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

High-intensity interval training (HIIT) is better than moderate-intensity continuous training (MICT) for improving health in overweight women with PCOS.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Women with different PCOS types have similar fertility treatment results.

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Isotretinoin effectively treats severe acne but has serious side effects and requires careful monitoring.